This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Shuangshuang Duan: Innovator in Tetrahydroisoquinoline Derivatives
Introduction
Shuangshuang Duan is a notable inventor based in Sichuan, China. She has made significant contributions to the field of biopharmaceuticals, particularly through her innovative work on tetrahydroisoquinoline derivatives. Her research focuses on the preparation and application of these compounds in medical treatments.
Latest Patents
Shuangshuang Duan holds a patent for "Tetrahydroisoquinoline derivatives, preparation process and use thereof." This patent encompasses the development of tetrahydroisoquinoline derivatives, including various forms such as pharmaceutically acceptable salts, esters, stereoisomers, tautomers, polymorphs, solvates, isotopically labeled compounds, metabolites, or prodrugs. The patent also details the preparation process of these compounds, their intermediates, and a pharmaceutical composition that includes them. The primary application of these derivatives is in the treatment or prevention of thromboembolic disorders.
Career Highlights
Shuangshuang Duan is currently employed at Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Her work at this company highlights her commitment to advancing biopharmaceutical research and development. With her expertise, she contributes to the innovative solutions that the company provides in the healthcare sector.
Collaborations
Shuangshuang Duan collaborates with esteemed colleagues, including Yongyong Wu and Chaolei Wang. These partnerships enhance her research efforts and contribute to the success of her projects.
Conclusion
Shuangshuang Duan is a pioneering inventor whose work on tetrahydroisoquinoline derivatives has the potential to impact the treatment of thromboembolic disorders significantly. Her contributions to the field of biopharmaceuticals are noteworthy and reflect her dedication to innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile